Back HBV-Related Conditions

HBV-Related Conditions

Coverage of the 2013 AASLD Liver Meeting

HIVandHepatitis.com coverage of the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2013) in Boston, November 1-5, 2013.

Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.

Full listing by topic

10/30/13

alt

Coverage of the 2012 AASLD Liver Meeting

HIVandHepatitis.com coverage of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2012) in Boston, November 9-13, 2012.

Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.

Full listing by topic

HIVandHepatitis.com AASLD 2012 conference section

11/13/12

alt

Hepatitis B Virus Infection Linked to Non-Hodgkin Lymphoma in South Korean Study

People with chronic hepatitis B virus (HBV) infection were almost twice as likely as uninfected individuals to develop non-Hodgkin lymphoma and certain other types of blood cell cancers, according to a large South Korean analysis described in the August 4, 2010 advance online edition of Lancet Oncology. Occurrence of lymphoma was uncommon overall, however, indicating that prevention and treatment of hepatitis B is unlikely to greatly affect lymphoma rates.

alt

Read more:

Lymphoma Chemotherapy Can Cause Severe Hepatitis B Reactivation

Chronic hepatitis B patients are at risk for recurrence or relapse when they undergo chemotherapy for lymphoma, despite receiving prophylaxis with lamivudine (Epivir-HBV), according to an Italian study presented at the recent 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2010) in Boston. Investigators recommended that other potentially more effective antiviral drugs should be studied for this indication.

Read more:

Bone Loss and Vitamin D Deficiency Are Common among People with Liver Cirrhosis

People with liver cirrhosis -- a potential outcome of chronic hepatitis B or C -- frequently experience bone loss, or reduced bone mineral density (BMD), and often have low vitamin D levels, according to an Indian study published in the July 28, 2009 issue of World Journal of Gastroenterology.

Read more: